Ifinix Corporation (INIX)

[sabeon01]

XCLR8R, let me try to clear some things up for you here, seeing as how you backdoor responded to my statement.

Let's say I am the CEO of a publicly traded company that has created a drug superior to that of any in its class(competition). Now let's say, that because of circumstances beyond my control, (I) decide to release this drug in a dilluted version, thus only equaling the effectiveness of my competitors drug. I'm also going to put this drug on the market free of charge until I can get these issues straightened out. While my company may benefit in the long run by allowing a free trial version, the current revenues of my company from this drug are ZERO. Furthermore, there is some underlying doubt as to whether or not this drug can be realeased in its full potency because "these circumstances beyond my control" have set back its release before.(I) can't lawfully state, before it happens, that everything is going to be okay, although I'm confident it will.

Bottom line is: zero revenue from new product at "launch" and no PPS increase in the long run from it unless it's proven that we have a superior product that is able to be distributed and marketed in its full capacity/capability.

Buying at the bid is not what's causing the PPS to shrink, it's individuals thinking that maybe they have seen this song and dance before. All of this............IMO!